Global gene expression analyses have further classified BC into four molecular subtypes with distinct gene expression patterns: the hormone receptor-related luminal A and luminal B tumors versus the hormone receptor-negative, HER2-enriched and basal-like tumors [4–6]. Here, NR4A1 is linked to breast cancer.